AVTX (Avalo Therapeutics) Net Margin %: 0.00% (As of Mar. 2026)

Avalo Therapeutics  (NAS:AVTX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Avalo Therapeutics Net Margin % Related Terms

The historical data trend for Avalo Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avalo Therapeutics Net Margin % Chart

Avalo Therapeutics Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
Net Margin %		Get a 7-Day Free Trial					-1,563.10	-230.78	-1,639.50	-7,965.76	-132,642.37

Avalo Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Net Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	-23,254.24	0.00

AVTX vs SANA, ANRO, REPL: Net Margin % Comparison

For the Biotechnology subindustry, Avalo Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avalo Therapeutics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avalo Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Avalo Therapeutics's Net Margin % falls into.

Avalo Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Avalo Therapeutics's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Avalo Therapeutics's Net Margin for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avalo Therapeutics Business Description